Head-to-Head

Enveric Biosciences, Inc. Common Stock vs. Johnson & Johnson

ENVB

Enveric Biosciences, Inc. Common Stock

$1.48 +4.23%

VS JNJ

Johnson & Johnson

$266.32 +0.28%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ENVBJNJ
Market Cap $6.36 million $640.02 billion
Revenue (TTM) — $97.93 billion
Net Income (TTM) — $21.04 billion

JNJ leads on 1 of 1 size & scale factors.

Valuation

ENVBJNJ
P/E Ratio — 30.90
Price / Book — 7.53
Price / Sales — 6.54

ENVB and JNJ split the valuation factors evenly.

Profitability

ENVBJNJ
Net Margin — 21.48%
Return on Equity — 24.76%

ENVB and JNJ split the profitability factors evenly.

Dividend

ENVBJNJ
Dividend Yield — 2.01%
Payout Ratio — 62.18

ENVB and JNJ split the dividend factors evenly.

Risk & Sentiment

ENVBJNJ
Short Interest 2.05% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: ENVB overview, ENVB financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.